Cargando…

Low Peripheral Nerve Conduction Velocities and Amplitudes Are Strongly Related to Diabetic Microvascular Complications in Type 1 Diabetes: The EURODIAB Prospective Complications Study

OBJECTIVE: Slow nerve conduction velocity and reduction in response amplitude are objective hallmarks of diabetic sensorimotor polyneuropathy. Because subjective or clinical indicators of neuropathy do not always match well with the presence of abnormal nerve physiology tests, we evaluated associati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Charles, Morten, Soedamah-Muthu, Sabita S., Tesfaye, Solomon, Fuller, John H., Arezzo, Joseph C., Chaturvedi, Nishi, Witte, Daniel R.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992206/ https://www.ncbi.nlm.nih.gov/pubmed/20823346 http://dx.doi.org/10.2337/dc10-0456

Ejemplares similares

Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in Europe: The EURODIAB Prospective Complications Study (PCS)
por: Soedamah-Muthu, Sabita S., et al.
Publicado: (2008)

Incident cardiovascular disease by clustering of favourable risk factors in type 1 diabetes: the EURODIAB Prospective Complications Study
por: Soulimane, Soraya, et al.
Publicado: (2022)

Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS)
por: Soedamah-Muthu, S. S., et al.
Publicado: (2008)

Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study
por: Engelen, Lian, et al.
Publicado: (2014)

MicroRNA 146a is associated with diabetic complications in type 1 diabetic patients from the EURODIAB PCS
por: Barutta, Federica, et al.
Publicado: (2021)

Dietary saturated fat and fibre and risk of cardiovascular disease and all-cause mortality among type 1 diabetic patients: the EURODIAB Prospective Complications Study
por: Schoenaker, D. A. J. M., et al.
Publicado: (2012)

Low 25-hydroxyvitamin D(2) and 25-hydroxyvitamin D(3) levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study
por: Engelen, Lian, et al.
Publicado: (2015)

Anti–Heat Shock Protein 27 Antibody Levels and Diabetes Complications in the EURODIAB Study
por: Burt, Davina, et al.
Publicado: (2009)

Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study
por: Gruden, Gabriella, et al.
Publicado: (2012)

Serum Heat Shock Protein 27 and Diabetes Complications in the EURODIAB Prospective Complications Study : A Novel Circulating Marker for Diabetic Neuropathy
por: Gruden, Gabriella, et al.
Publicado: (2008)

QTc Interval Prolongation Is Independently Associated With Severe Hypoglycemic Attacks in Type 1 Diabetes From the EURODIAB IDDM Complications Study
por: Gruden, Gabriella, et al.
Publicado: (2012)

NH(2)-Terminal Probrain Natriuretic Peptide Is Associated With Diabetes Complications in the EURODIAB Prospective Complications Study: The role of tumor necrosis factor-α
por: Gruden, Gabriella, et al.
Publicado: (2012)

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
por: Peeters, Stijn A, et al.
Publicado: (2015)

Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
por: Peeters, Stijn A, et al.
Publicado: (2015)

Diabetic Microvascular Complications
por: Migdalis, I., et al.
Publicado: (2018)

High Prevalence of Microvascular Complications in Adults With Type 1 Diabetes and Newly Diagnosed Celiac Disease
por: Leeds, John S., et al.
Publicado: (2011)

Inflammation and diabetic retinal microvascular complications
por: Zhang, Wenbo, et al.
Publicado: (2011)

Inflammation in the pathogenesis of microvascular complications in diabetes
por: Nguyen, Dung V., et al.
Publicado: (2012)

MicroRNA and Microvascular Complications of Diabetes
por: Barutta, F., et al.
Publicado: (2018)

The Role of Biofactors in Diabetic Microvascular Complications
por: Ziegler, Dan, et al.
Publicado: (2022)

Genetics of diabetes-associated microvascular complications
por: Lyssenko, Valeriya, et al.
Publicado: (2023)

Comment on: Gruden et al. Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2012;35:1598–1604
por: Giménez, Marga, et al.
Publicado: (2012)

Association between brachial-ankle pulse wave velocity and microvascular complications in type 2 diabetes mellitus
por: Pei, Yifei, et al.
Publicado: (2023)

Response to Comment on: Gruden et al. Severe Hypoglycemia and Cardiovascular Disease Incidence in Type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 2012;35:1598–1604
por: Gruden, Gabriella, et al.
Publicado: (2012)

The Ubiquitin-Proteasome System and Microvascular Complications of Diabetes
por: Yadranji Aghdam, Saeed, et al.
Publicado: (2013)

Is cognitive impairment the fourth diabetic microvascular complication?
por: Kawamura, Takahiko, et al.
Publicado: (2011)

Vaccinium as Potential Therapy for Diabetes and Microvascular Complications
por: Huang, Hui, et al.
Publicado: (2023)

Cardiovascular risk factor management of myocardial infarction patients with and without diabetes in the Netherlands between 2002 and 2006: a cross-sectional analysis of baseline data
por: Soedamah-Muthu, Sabita S, et al.
Publicado: (2012)

Diabetic Peripheral Microvascular Complications: Relationship to Cognitive Function
por: Ba-Tin, Lorraine, et al.
Publicado: (2011)

Microvascular Complications in Adolescents with Type 1 Diabetes Mellitus
por: Demirel, Fatma, et al.
Publicado: (2013)

Preventing microvascular complications in type 1 diabetes mellitus
por: Viswanathan, Vijay
Publicado: (2015)

Editorial: Cell-Based Therapies for Diabetic Microvascular Complications
por: Bhatwadekar, Ashay D.
Publicado: (2015)

Effects of Incretin-Based Therapies on Diabetic Microvascular Complications
por: Kang, Yu Mi, et al.
Publicado: (2017)

The role of protein oxidation in the development of diabetic microvascular complications
por: Mertoglu, Cuma, et al.
Publicado: (2021)

Determinant of Osteopontin Levels in Microvascular Complications in Patients with Diabetes
por: Nawaz, Shaik Sarfaraz, et al.
Publicado: (2022)

The role of protein kinase C in diabetic microvascular complications
por: Pan, Deng, et al.
Publicado: (2022)

COVID-19 and the hidden threat of diabetic microvascular complications
por: Zaghloul, Hadeel, et al.
Publicado: (2022)

Prospects of stem cell therapy for diabetic microvascular complications
por: Naruse, Keiko
Publicado: (2022)

Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways
por: Zakir, Mehreen, et al.
Publicado: (2023)

Development of a salutogenic intervention for healthy eating among Dutch type 2 diabetes mellitus patients
por: Polhuis, Kristel C M M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_acsu1qmsijch0h4or1g28j8th2